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The term "exercise induced bronchoconstriction" is preferred to that of "exercise induced asthma" since asthma is a chronic condition which is not induced by a single bout of exercise. EIB is more likely in people with asthma, but it also occurs in individuals without asthma. 1 6 EIB is characterised by falls in forced expiratory volume in one second (FEV 1 ) after exercise, while in people with asthma there is persistent airway inflammation and recurrent symptoms outside of exercise (that is, with allergen exposure or upper respiratory infections). Often, at baseline there is evidence of reversible lower airway obstruction. Pharmacological management for persistent asthma requires daily anti-inflammatory, preventive medications. However, airway inflammation and remodelling also occur in cold weather athletes with and without asthma and EIB. 
What triggers an episode of EIB?
EIB typically occurs after high intensity aerobic exercise during which high ventilation (>85% of maximal voluntary ventilation) dehydrates the respiratory mucosa and leads to a transient increase in airway osmolarity, mast cell activation with mediator release (including histamine, serine proteases, prostaglandins, and leukotrienes 8 ), and bronchoconstriction. Dry environments exacerbate EIB because of greater respiratory water loss. Exacerbations due to cold air are because of the reduced water content of the air rather than the low temperature. Increased exposure to allergens and respiratory irritants may exacerbate bronchoconstriction during high ventilation exercise. 9 EIB may be seasonal in some individuals with atopy, 10 11 although research on this association is limited. Figure 1⇓ shows the pathogenesis of EIB and how diagnostic tests and management interventions work.
Who gets EIB?
EIB can occur in children and adults of various fitness levels, ranging from recreational to elite competitors, 15 16 with a reported prevalence of 10-50% or greater in high level athletes, depending on sport and surveillance or diagnostic methodology. 17 18 Individuals who are exposed to high concentrations of airborne particulate matter during high ventilation exercise have an increased incidence of EIB (see box 1).
How does EIB present?
Individuals with EIB typically complain of breathlessness, wheezing, cough, and chest tightness during or after exercise. Athletes may seek medical input because they feel that these symptoms limit their sports performance. However, the non-specific nature of the symptoms can make it hard to reach a firm diagnosis. A systematic review concluded that there are currently no questionnaires with sufficient sensitivity and specificity to diagnose EIB based on symptoms and signs alone.
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How is EIB accurately diagnosed?
Algorithms for the diagnosis of EIB are available (see fig  2⇓) . 1 8 18 21 Formal diagnosis requires either direct or indirect challenge tests designed to induce bronchoconstriction. Direct challenge uses a nebulised drug to stimulate the airway smooth muscle, whereas indirect challenge attempts to dehydrate the mucosa (see box 2). 22 Spirometry before and at 5, 10, 15, and 20 minutes after the stimulus measures the change in FEV 1 . A reduction of >10-15% in FEV 1 at two consecutive post-challenge time points is considered diagnostic for EIB, though specific
What you need to know
• Exercise induced bronchoconstriction (EIB) is most common in individuals with asthma but also occurs in those without
• EIB is commonly misdiagnosed because its symptoms (such as shortness of breath, chest tightness, wheezing, and cough) are neither sensitive nor specific
• EIB is most accurately diagnosed by using spirometry to measure forced expiratory volume in one second (FEV 1 ) before and after a high intensity exercise challenge in dry air or eucapnic voluntary hyperpnoea
• Short acting β agonists are recommended first line treatment for confirmed EIB, used only "as required" rather than daily to avoid tolerance and potential exacerbations
• People with EIB symptoms and a negative bronchoprovocation test or with documented EIB and ongoing symptoms despite treatment should have their management and diagnosis reviewed
• Exercise induced laryngeal obstruction is a relatively common cause of breathlessness in athletes, which may mimic or occur alongside EIB
Methods
We searched Medline for the terms "exercise induced bronchoconstriction" or "exercise induced asthma" or "asthma" and "athlete" or "exercise." We also evaluated our personal archives of peer reviewed references. We gave priority to systematic reviews and meta-analyses, as well as professional society task force and practice parameter papers. When these comprehensive resources were insufficient or published more than five years ago, we used Google Scholar to identify more recent prospective epidemiological studies and randomised clinical trials which cited these references.
Box 1: Athletes who show increased incidence of EIB when exposed to high concentrations of airborne particulate matter during high ventilation exercise 9 • Individuals participating in physical activity in athletic fields and fitness trails adjacent to roads with high traffic volume
• Those who regularly skate at ice rinks where ice resurfacers are powered by fossil fuels
• Risks among winter sports athletes are increased by the dry ambient air
• Swimmers who train in indoor chlorinated swimming pools experience inhalation exposure to chloramines (respiratory irritants that arise from the reaction of nitrogenous waste products with chlorine 19 ) recommendations vary (for example, the European Respiratory Society recommends a >12% fall in FEV 1 ). 18 Diagnostic thresholds are based on a greater post-challenge decrease in FEV 1 than that shown by 95-99% of the healthy population (2-3 standard deviations beyond the mean response). 23 About half of athletes with EIB will have a negative exercise challenge test result, so two tests may need to be done to exclude the diagnosis. 24 Challenge tests are designed to trigger a bronchoconstriction and may provoke a severe attack. With the exception of the mannitol challenge, challenge tests should be conducted only in facilities where bronchodilator, supplementary oxygen, resuscitation equipment, and medical staff are readily available in the event of a severe response. 29 Direct and indirect challenge tests are contraindicated in patients with baseline impairments in FEV 1 (<70-80% of predicted).
Indirect tests are preferable to direct tests as they replicate the environmental conditions and the pathophysiology, including the inflammatory mediator release, that trigger respiratory symptoms. The most widely used indirect tests are high intensity exercise and eucapnic voluntary hyperpnoea (see box 2). Both tests use high ventilation rates in dry air conditions to dehydrate the respiratory mucosa. High intensity exercise has the advantage of exposing the individual to sport-specific physiological demands, whereas eucapnic voluntary hyperpnoea can be conducted in a controlled manner, which allows for easy standardisation between facilities.
What are the consequences of misdiagnosing EIB?
Diagnosis of EIB based on symptoms without proper adherence to established protocols has led to a high rate of false positive diagnoses, and consequent unnecessary use of bronchodilators. 32 However, individuals with false negative results (box 3) may not receive treatment and may continue to experience EIB. This may take the form of an occasional nuisance or severe impairment that causes them to stop taking part in sport and lose the health benefits of physical activity. 20 Though rare, there are reports of asthma related sudden death during sports participation, with one epidemiological study identifying 61 deaths in seven years in the United States. 35 
What can mimic EIB?
Other conditions can cause shortness of breath during exercise and may be mistaken for EIB. Asthma and exercise induced laryngeal obstruction (EILO, previously called vocal cord dysfunction) are two of the most common (see table 2⇓ ).
Exercise induced laryngeal obstruction (EILO)
Some athletes experience EILO with or without EIB. 36 One study reported an incidence of 5% in 370 developmental or elite athletes, with about half of those with EILO also testing positive for EIB. 37 Among athletes referred for evaluation of asthma, about 35% had EILO, and, of these, approximately 39% also tested positive for EIB or asthma. 38 Thus, EILO and EIB are common comorbidities, but most individuals with EILO may not have EIB.
EILO often produces inspiratory stridor that can be confused with the wheeze of EIB. Stridor associated with EILO occurs during inspiration in the laryngeal region during exercise and resolves quickly after stopping exercise, whereas the wheeze associated with EIB typically occurs during exhalation after cessation of exercise. EILO should be considered in athletes who have symptoms of EIB but who test negative for it in bronchoprovocation testing, or in those who have documented EIB but continue to experience symptoms with exercise despite appropriate management. If EILO is suspected, the diagnosis 
Mannitol challenge
• Provides a safe alternative to the other tests because it allows clinicians to produce bronchoconstriction in a controlled and stepwise manner with increasing amounts of inhaled powdered mannitol, which increases osmolarity until a 15% decrease in FEV 1 occurs. • Insufficient exercise intensity (that is, <90% of maximum heart rate)
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• Performing a "confirmatory" challenge test while using previously prescribed medication based on symptoms. See table 1⇓ for details
• Using a peak expiratory flow meter as a diagnostic tool instead of a spirometer (lacks appropriate sensitivity and positive predictive value 33 34 )
• Test performed at the wrong time of the year in individuals with seasonal EIB 10 11 can be confirmed with laryngoscopy during high intensity exercise, 39 and this may be performed simultaneously with a dry air challenge to test for concomitant EIB.
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What are the treatment options for EIB?
Non-pharmacological management
A systematic review and meta-analysis 2 found that, before vigorous intensity exercise, a warm-up procedure that included continuous high intensity activity (such as 6 minutes of hard uphill running) or sprint interval bouts reduced the later fall in FEV 1 . Although individuals vary in their airway response, athletes with EIB may wish to try including some sprint interval exercise (such as six to eight bouts of 30 second sprints with 45-120 seconds rest between 2 ) in their warm-up routine. Individuals with EIB may also try to avoid exercising in areas where they are exposed to high levels of air pollution and airborne allergens, and dry environments when possible.
Should people with EIB avoid exercise?
Exercise is of potential benefit to asthmatic patients with EIB and, if their asthma is well controlled, their exercise should not be limited. A systematic review and meta-analysis revealed that exercise training improved quality of life, reduced symptoms of asthma, decreased EIB and bronchial hyper-responsiveness, and attenuated the fall in FEV 1 . 41 Patients with EIB should be encouraged to continue taking exercise while adhering to their management plan, and should seek further medical evaluation if their symptoms do not resolve.
Pharmacological management
β agonists-People with EIB, with or without asthma, should be prescribed short acting (1-6 hours, depending on drug) β agonist bronchodilators, which should be used only as needed. Long acting β agonists are not used as sole therapy for either EIB or asthma because of the potential risk of severe asthma exacerbations and death. 42 A systematic review (including studies of adults and children with EIB) found that a single dose of a β agonist was effective in preventing EIB but confirmed that daily use leads to tolerance, which reduces its effectiveness as a rescue medication. 43 β agonists can be used before exercise two to four times a week to prevent bronchoconstriction or taken as a rescue inhaler as needed, but they should not be used daily.
1 8 44 If β agonists are needed more frequently, then a leukotrienes receptor antagonist (such as montelukast) or a daily inhaled corticosteroid should be considered.
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Inhaled corticosteroids-Patients with known asthma who also have EIB should be managed with inhaled corticosteroids to reduce airway inflammation. Inhaled corticosteroids are most effective when administered daily and may take up to four weeks to reach maximal effectiveness. 
When to refer
• Facilities not available to perform dry air exercise challenge or EVH
• Repeated negative result on properly conducted indirect challenge tests
• Symptoms are not improved despite proper medication use
• Non-reversible airway obstruction
Questions for future research
• Can a screening questionnaire guide clinicians to differentiate EIB from other forms of breathlessness associated with exercise?
• Can EIB phenotypes be categorised according to symptoms (such as individuals who cough but do not wheeze versus individuals who wheeze but do not cough), inflammatory cells or mediators, genetics (such as glutathione S-transferase polymorphisms), or environmental triggers (such as pollutant exposure versus dry and cold air exposure) in order to improve patient specific treatment strategies?
• Why is it that, although EIB and EILO can exist independently, comorbidity is common?
• Tiotropium bromide is used primarily for managing chronic obstructive pulmonary disease. It shows promise as an add-on therapy to decrease exacerbations and improve post-challenge FEV 1 in moderate to severe asthma. Could it be used for prophylaxis or rescue in patients with mild asthma or EIB without apparent asthma?
Tips for non-specialists
• To avoid misdiagnosis, EIB should never be diagnosed on the basis of signs and symptoms alone
• Diagnosis should include changes in FEV 1 before and after a challenge test
• Positive field test results may be used to diagnoses EIB, but a negative field test result does not rule out EIB
• Exercise challenge and eucapnic voluntary hyperpnoea tests should strictly adhere to guidelines and may need to be repeated 
How patients were involved in the creation of this article
A patient story is included in this article Tables   Table 1| Guidelines 1⇓ ). †Field tests may be attempted before laboratory tests: a positive field test is diagnostic for EIB, but false negative field tests are common, 27 28 so laboratory tests should be performed before EIB is excluded. ‡It may be necessary to perform an indirect test on two separate occasions before EIB can be ruled out. 24 §Ensure the patient is taking medication as directed.) 
